Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! Download free report on life science investment in China.

IMCAS and TB Alliance will Search TCM for TB Drug

publication date: Apr 3, 2009
View a Printer Friendly version of this page, allowing you to print the page.

A new partnership has been established that will investigate traditional Chinese medicines for a new, more effective treatment of tuberculosis. The Institute of Microbiology (IMCAS), a member institute of the Chinese Academy of Sciences, will team up with the Global Alliance for TB Drug Development (TB Alliance) to do the work. IMCAS, which is located in Beijing, has completed a pilot screen that identified 24 natural product extracts as having potential anti-tubercular activity. IMCAS and the TB Alliance will collaborate to test these extracts further. More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China